Rapid Mycoplasma Testing by Anyone, Anywhere, Anytime
RAPID MYCOPLASMA TESTING BY ANYONE, ANYWHERE, ANYTIME
bioMérieux is launching an innovative rapid solution for biopharmaceutical industry, BIOFIRE® MYCOPLASMA, that will revolutionize the way to perform mycoplasma control tests.
All current rapid methods available are complicated, require a specific molecular laboratory organization, and highly trained personnel. The BIOFIRE® Mycoplasma solution provides results in less than 1h, is fully automated and requires only 2 minutes of hands-on-time.
Thanks to its ease-of-use and small footprint, BIOFIRE® Mycoplasma allows testing outside of the expert lab, near sample collection sites, by personnel non-specialized in mycoplasma detection.
“BIOFIRE® Mycoplasma offers our clients the possibility of having a very simple means of closely monitoring the risk of contamination at every stage in their production process,” explains Sylvanie Cassard Guilloux, Global Solution Manager - Healthcare.
It’s an innovation that brings massive added-value in safeguarding bioproduction procedures, minimizing the impact of the cost of a possible contamination in the factory, and gaining valuable time in releasing batches